(Q38066414)

28 August 2017

1 reference

title

The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade (English)

1 reference

28 August 2017

9

Yehuda Shoenfeld

1 reference

28 August 2017

8

Miri Blank

1 reference

28 August 2017

4

Loic Guillevin

1 reference

Oscar-Danilo Ortega-Hernandez

28 August 2017

series ordinal

2

object named as

Oscar-Danilo Ortega-Hernandez

1 reference

28 August 2017

5

Hans-Jurgen Thiesen

1 reference

28 August 2017

6

Arie Altman

1 reference

28 August 2017

Martine Szyper-Kravitz

series ordinal

7

object named as

Martine Szyper Kravitz

1 reference

28 August 2017

Nina Svetlicky

1

1 reference

28 August 2017

Luc Mouthon

series ordinal

3

1 reference

28 August 2017

publication date

11 December 2012

1 reference

Journal of Clinical Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

33 Suppl 1

1 reference

28 August 2017

page(s)

S27-32

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-012-9842-5

28 August 2017

exact match

0 references

cites work

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Intravenous immunoglobulin in immunodeficiency states: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Evidence for the use of intravenous immunoglobulins--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Toward molecular targeting with specific intravenous immunoglobulin preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Induction and treatment of the antiphospholipid syndrome--lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Autoimmune blistering diseases of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

21 January 2018

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

5th International symposium on IVIG: IVIG in the third millenium, 25-27 September 2003, Interlaken, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Successful treatment of a patient with severe Churg-Strauss syndrome by a combination of pulse corticosteroids, pulse cyclophosphamide, and high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Identification of a receptor required for the anti-inflammatory activity of IVIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9842-5

Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement

21 January 2018

1 reference

12 December 2020

BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer

1 reference

12 December 2020

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway

1 reference

12 December 2020

Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus

1 reference

12 December 2020

Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis

1 reference

12 December 2020

Churg-strauss syndrome

1 reference

12 December 2020

Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins

1 reference

12 December 2020

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model

1 reference

12 December 2020

Use of intravenous immunoglobulin in livedo vasculitis

1 reference

12 December 2020

Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view

1 reference

12 December 2020

Hyperimmune gammaglobulin for the treatment of West Nile virus encephalitis

1 reference

12 December 2020

Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg)

1 reference

12 December 2020

Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction

1 reference

12 December 2020

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis

1 reference

12 December 2020

Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan

1 reference

12 December 2020

Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.

1 reference

12 December 2020

10.1007/S10875-012-9842-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1001113146

0 references

1 reference